Logo image of RFL

RAFAEL HOLDINGS INC-CLASS B (RFL) Stock Fundamental Analysis

USA - NYSE:RFL - US75062E1064 - Common Stock

1.32 USD
-0.01 (-0.75%)
Last: 10/17/2025, 8:04:00 PM
1.35 USD
+0.03 (+2.27%)
Pre-Market: 10/20/2025, 8:28:19 AM
Fundamental Rating

2

RFL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. RFL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RFL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RFL has reported negative net income.
In the past year RFL has reported a negative cash flow from operations.
RFL had negative earnings in each of the past 5 years.
In the past 5 years RFL always reported negative operating cash flow.
RFL Yearly Net Income VS EBIT VS OCF VS FCFRFL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of RFL (-21.18%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -28.41%, RFL is in the better half of the industry, outperforming 60.73% of the companies in the same industry.
Industry RankSector Rank
ROA -21.18%
ROE -28.41%
ROIC N/A
ROA(3y)-47.6%
ROA(5y)-33.28%
ROE(3y)-55.93%
ROE(5y)-39.35%
ROIC(3y)N/A
ROIC(5y)N/A
RFL Yearly ROA, ROE, ROICRFL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 74.86%, RFL belongs to the top of the industry, outperforming 82.20% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for RFL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RFL Yearly Profit, Operating, Gross MarginsRFL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

4

2. Health

2.1 Basic Checks

RFL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RFL has been increased compared to 1 year ago.
RFL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, RFL has a worse debt to assets ratio.
RFL Yearly Shares OutstandingRFL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RFL Yearly Total Debt VS Total AssetsRFL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -2.01, we must say that RFL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of RFL (-2.01) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.01 indicates that RFL is not too dependend on debt financing.
RFL's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. RFL outperforms 58.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -2.01
ROIC/WACCN/A
WACC8.71%
RFL Yearly LT Debt VS Equity VS FCFRFL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

RFL has a Current Ratio of 3.85. This indicates that RFL is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.85, RFL is doing good in the industry, outperforming 62.30% of the companies in the same industry.
RFL has a Quick Ratio of 3.82. This indicates that RFL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.82, RFL is in the better half of the industry, outperforming 63.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.85
Quick Ratio 3.82
RFL Yearly Current Assets VS Current LiabilitesRFL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.01% over the past year.
The Revenue has grown by 35.06% in the past year. This is a very strong growth!
Measured over the past years, RFL shows a very negative growth in Revenue. The Revenue has been decreasing by -33.59% on average per year.
EPS 1Y (TTM)21.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.96%
Revenue 1Y (TTM)35.06%
Revenue growth 3Y-7.31%
Revenue growth 5Y-33.59%
Sales Q2Q%7.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RFL Yearly Revenue VS EstimatesRFL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RFL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RFL Price Earnings VS Forward Price EarningsRFL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RFL Per share dataRFL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RFL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAFAEL HOLDINGS INC-CLASS B

NYSE:RFL (10/17/2025, 8:04:00 PM)

Premarket: 1.35 +0.03 (+2.27%)

1.32

-0.01 (-0.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)06-17 2025-06-17
Earnings (Next)11-03 2025-11-03
Inst Owners10.26%
Inst Owner Change0%
Ins Owners45.18%
Ins Owner Change3.7%
Market Cap46.32M
Analysts0
Price TargetN/A
Short Float %1.01%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 63.28
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 2.35
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.02
BVpS2.3
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.18%
ROE -28.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.86%
FCFM N/A
ROA(3y)-47.6%
ROA(5y)-33.28%
ROE(3y)-55.93%
ROE(5y)-39.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.88%
Cap/Sales 7.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.85
Quick Ratio 3.82
Altman-Z -2.01
F-Score4
WACC8.71%
ROIC/WACCN/A
Cap/Depr(3y)26.37%
Cap/Depr(5y)24.37%
Cap/Sales(3y)9.31%
Cap/Sales(5y)13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.06%
Revenue growth 3Y-7.31%
Revenue growth 5Y-33.59%
Sales Q2Q%7.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y83.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.86%
OCF growth 3YN/A
OCF growth 5YN/A